The firm received the CE IVD mark for Amplidiag Easy, an automated system that enables nucleic acid extraction and PCR setup directly from stool samples.
The agreement with PerkinElmer's Wallac Oy subsidiary will bring Mobidiag's real-time PCR-based gastrointestinal tests to a new market.
The deal will help the Finnish diagnostics company expand its offerings of PCR-based gastrointestinal diagnostic tests.
The deal is the latest in a series of such arrangements Mobidiag has inked for its Amplidiag diagnostic product line in recent months.
The deal marks the latest in a series of arrangements the company has signed for distribution of its Amplidiag products internationally.
The Finnish firm is hoping to finalize manufacturing, validation, and commercialization of its new sample-to-result infectious disease diagnostics platform.
The deal covers Mobidiag's line of PCR-based Amplidiag tests for gastrointestinal infections, as well as its automated Amplidiag Easy platform.
Under a four-year agreement, Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway.
The latest addition to the firm's qPCR-based Amplidiag line of tests detects H. pylori as well as that pathogen's resistance to clarithromycin.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.